Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer
0 comments.
Click here to read/write comments.
Topics:
Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.